Skip to content
10-K

Annual Report

APELLIS PHARMACEUTICALS, INC.

0000950170-25-029507

← back to feed
Filed
Feb 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 19, 2025 125.52M sh
Sga Expense FY 2024 · Dec 31, 2022 $277.16M